U.S. Personal Products Stock News

What Recent Performance Says About Napco Security Technologies Without a fresh headline event to react to, Napco Security Technologies (NSSC) is still drawing interest as investors look at how its recent share performance lines up with its current fundamentals. See our latest analysis for Napco Security Technologies. The recent share price return tells a story of building momentum, with Napco Security Technologies posting a 19.05% 1 month share price return and a 1 year total shareholder...

Dole's Colada Royale Pineapple has been named a 2026 Best New Product Awards Winner by BrandSpark International and Newsweek. The recognition highlights Dole's focus on product development within the fresh produce category. The award spotlights Colada Royale Pineapple as a differentiated offering in Dole's portfolio. Dole (NYSE:DOLE) operates across the fresh fruit and vegetable value chain, so a branded product win in a consumer awards program speaks directly to how its R&D and marketing...

Crinetics Pharmaceuticals (NasdaqGS:CRNX) reported positive clinical trial results for its congenital adrenal hyperplasia treatment. The company also announced positive initial sales for its oral therapy for acromegaly, alongside progress on related regulatory milestones. These updates highlight recent clinical and commercial developments in Crinetics' rare endocrine disease portfolio. Crinetics Pharmaceuticals focuses on therapies for rare endocrine conditions, an area where treatment...

What the latest earnings and buyback update means for Apollo Commercial Real Estate Finance (ARI) Apollo Commercial Real Estate Finance (ARI) just released fourth quarter and full year 2025 results, reporting quarterly income of US$29.2 million and a full year return to profitability, alongside the completion of a multi year share repurchase program. See our latest analysis for Apollo Commercial Real Estate Finance. The latest earnings rebound and completion of a multi year buyback sit...

The U.S. decision to impose a 15% global tariff for up to 150 days has put Starbucks (SBUX) in sharper focus, as investors reassess a business that is heavily tied to international sourcing and overseas operations. See our latest analysis for Starbucks. Despite the tariff headlines, Starbucks’ 90 day share price return of 10.32% and year to date share price return of 12.87% point to improving momentum. However, the 1 year total shareholder return decline of 13.95% shows that longer term...

If you are wondering whether Xcel Energy's current share price offers good value, this article will walk through what the numbers are saying about the stock today. Xcel Energy shares recently closed at US$83.35, with returns of 2.2% over 7 days, 11.1% over 30 days, 11.6% year to date, 21.6% over 1 year, 41.3% over 3 years and 65.1% over 5 years. This gives useful context before looking at valuation. Recent news around Xcel Energy has focused on its role as a regulated utility and how...

If you are wondering whether Service Corporation International's current share price lines up with its underlying value, this article will walk through what the data is actually saying about the stock. The shares recently closed at US$79.45, with returns of a 0.3% decline over the last 7 days, a 2.1% decline over 30 days, a 2.9% gain year to date, 1.3% over 1 year, 22.4% over 3 years and 74.4% over 5 years, which gives useful context before comparing that price to different valuation...

Boise Cascade (BCC) has drawn fresh attention after recent trading left the shares with a year-to-date total return of 8.7% and a 1-year total return decline of 21.5%. See our latest analysis for Boise Cascade. Recent trading has been weak, with a 7 day share price return of 6.9% and a 30 day share price return of 4.5%. However, the year to date share price return of 8.7% contrasts with a 1 year total shareholder return decline of 21.5%, while the 5 year total shareholder return of 103.8%...

If you are wondering whether MakeMyTrip at around US$55 a share still offers value, the key question is how its current price compares with what the business might reasonably be worth. The stock has seen mixed returns, with a 1.7% decline over the last week, an 11.7% decline over the last month, a 32.5% decline year to date, but a 118.8% gain over three years and a 54.0% gain over five years. These shifts can change how the market views both its growth potential and its risk profile. Recent...

For investors wondering whether MKS at around US$253 a share is still a worthwhile entry, or if most of the value is already on the table, this article walks through what the numbers currently suggest. The stock has been volatile over different time frames, with a 2.7% decline over the last 7 days, a 16.9% return over 30 days, a 50.7% return year to date and a 155.8% return over the past year, while the 3 year and 5 year returns sit at 182.0% and 53.5% respectively. Recent coverage around...

Steel Dynamics, together with SGH Ltd, has submitted a revised joint bid to acquire BlueScope Steel's North American operations. The proposed deal would enlarge Steel Dynamics' North American presence in flat-rolled and value-added steel products. Corporate Knights has again named Steel Dynamics as the global leader in steel industry sustainability, reflecting its circular manufacturing model. For investors watching NasdaqGS:STLD, these updates come as the stock trades around $196.01, with...

Wondering whether Innospec's current share price still reflects its underlying worth, or if the market is mispricing it, is a fair question for anyone tracking specialty chemicals stocks. Over the past week the stock has recorded a 8.8% decline, with a 2.3% decline over 30 days, a 3.5% gain year to date, and a 20.9% decline over one year, while the three and five year returns stand at 25.8% and 16.4% declines respectively. These moves have kept Innospec on the radar of investors who are...

CRH (NYSE:CRH) completed more than three dozen acquisitions in 2025. The company acquired Eco Material Technologies, described as a transformative deal for its portfolio. Management is preparing for expected strength in U.S. infrastructure spending in 2026, including state and federal highway projects. CRH, a major player in construction materials and solutions, is using acquisitions to build out its U.S. footprint and broaden its mix of products and services. The Eco Material Technologies...

Capricor Therapeutics recently advanced its lead candidate Deramiocel into phase 3 trials for Duchenne muscular dystrophy while progressing preclinical work on its exosome-based SARS-CoV-2 vaccine and StealthX exosome platform. This pipeline momentum, coupled with unanimous positive analyst coverage, highlights how central Deramiocel and exosome technologies have become to the company’s long-term thesis. Next, we’ll examine how Deramiocel’s phase 3 progress and upbeat analyst sentiment feed...

T. Rowe Price Group (TROW) has attracted fresh attention after recent share price weakness, with the stock showing negative returns over the month and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for T. Rowe Price Group. At a share price of $93.06, T. Rowe Price Group has seen a 1 day share price return of 2.43% decline and a 30 day share price return of 11.90% decline, while its 1 year total shareholder return of 8.04%...

If you are wondering whether Brown-Forman is fairly priced or offering value right now, this article walks through the key numbers that matter. The share price closed at US$30.20 most recently, with returns of 0.8% over 7 days, 9.5% over 30 days and 15.5% year to date, compared with a 5.2% decline over 1 year, a 50.8% decline over 3 years and a 54.3% decline over 5 years. Recent coverage of Brown-Forman has focused on how the spirits group is positioned in the branded alcohol market and how...

If you are wondering whether Ternium's current share price gives you good value, this article walks through what the numbers actually say and how that lines up with different valuation methods. Ternium's stock closed at US$43.33, with a 1 year return of 59.4% and a 5 year return of 96.2%. This comes even though the shares show a 0.7% decline over 7 days, a 1.1% decline over 30 days, and a 10.7% gain year to date. Recent coverage has put a spotlight on how investors are weighing steel demand,...

If you are wondering whether Tenet Healthcare's current share price lines up with its underlying value, this article is designed to walk you through that question step by step. Tenet Healthcare's stock last closed at US$233.77, with returns of 1.2% over 7 days, 23.8% over 30 days, 17.2% year to date, 77.7% over 1 year and 299.3% over 3 years. These figures can change how investors think about both upside and risk. Recent news around Tenet Healthcare has focused on its role in the US hospital...

With Manchester United stock trading at around US$17.40, this article considers whether that price represents a bargain or reflects the club's famous name, and explores what the current market valuation might be implying about the club's overall worth. The share price has been relatively steady in the very short term, with a 0.2% decline over the last 7 days, a 1.3% gain over 30 days, and returns of 10.3% year to date and 18.0% over the past year, compared with weaker figures over 3 and 5...

If you are wondering whether Teva Pharmaceutical Industries is still good value after its recent run, this article walks through what the current share price might be implying about the company. Teva's share price last closed at US$33.91, with returns of 6.6% over the past 30 days, 9.6% year to date and 102.1% over the last year. The 3 year and 5 year returns sit at 242.5% and 210.5% respectively, which raises the question of how much optimism is already reflected in the price. Recent...

AMC Entertainment Holdings (AMC) just posted its FY 2025 numbers with Q4 revenue of US$1,288.3 million, a basic EPS loss of US$0.25, and net income excluding extra items showing a loss of US$127.4 million, while trailing 12 month figures sit at US$4.8 billion of revenue, a basic EPS loss of US$1.34, and a net loss of US$632.4 million. Over recent quarters, the company has seen quarterly revenue move from US$862.5 million in Q1 2025 to between roughly US$1.3 billion and US$1.4 billion through...

If you are wondering whether HF Sinclair is still good value after its recent run, or if the price already reflects most of the story, this article will walk you through what the current share price could be implying. The stock recently closed at US$49.59, with a 7 day return of 15.3% decline, a 30 day return of 0.8% decline, a 1 year return of 41.1% and a 5 year return of 50.6%. These moves sit against a backdrop of ongoing interest in US energy stocks, where investors have been weighing...

If you are wondering whether Provident Financial Services is offering fair value at around US$21.93 per share, you are not alone. This article will walk through what that price really implies. The stock has seen mixed returns recently, with a 4.5% decline over the last 7 days, a 6.5% gain over the last 30 days, 11.0% year to date, and 29.8% over the past year, while the 3 year and 5 year returns sit at 9.9% and 36.1% respectively. Recent news flow around regional banks and funding conditions...

Edison International (NYSE:EIX) has introduced a Wildfire Recovery Compensation Program for Eaton Fire victims. The program aims to provide compensation to tens of thousands of affected residents and businesses. The announcement comes as the company continues to face wildfire related legal and financial liabilities. Edison International, the parent company of Southern California Edison, operates as a regulated electric utility and is closely tied to wildfire risk across its service...